147 related articles for article (PubMed ID: 1360842)
1. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
[TBL] [Abstract][Full Text] [Related]
5. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
Adejare A; Deal SA; Day MS
Chirality; 1999; 11(2):144-8. PubMed ID: 9951404
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
[TBL] [Abstract][Full Text] [Related]
9. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
Leclerc G; Decker N; Schwartz J
Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines.
Balsamo A; Lapucci A; Macchia B; Macchia M; Orlandini E; Rossello A; Ferni G; Pinza M
Farmaco; 1995 Apr; 50(4):239-43. PubMed ID: 7669168
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
12. [Beta-1 and beta-2 blocking activities of a new series of (arylalkoxy) propanolamines].
Rosell G; Mauleón D; Pujol MD; Granados R
Arch Farmacol Toxicol; 1986 Apr; 12(1):65-70. PubMed ID: 2874776
[No Abstract] [Full Text] [Related]
13. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
15. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
Lehmann D; Eckardt R; Faust G; Fiedler W
Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
[TBL] [Abstract][Full Text] [Related]
16. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
Meyer RF; Stratton CD; Hastings SG; Corey RM
J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
[No Abstract] [Full Text] [Related]
17. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
[No Abstract] [Full Text] [Related]
18. Cardioselective beta-adrenoceptor blocking actions of some 2-methoxyphenylethanolamines in guinea pig tissues.
Letts LG; Temple DM; Williams LR
Circ Res; 1980 Jun; 46(6 Pt 2):I51-2. PubMed ID: 6103760
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on beta-adrenolytic potencies of some new phenoxyaminopropanol derivatives and celiprolol.
Mlynárová R; Racanská E
Pharmazie; 1997 Mar; 52(3):234-7. PubMed ID: 9109170
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
